Solutions

Online Inquiry

Replication-Competent Virus Testing Services

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Replication-competent virus (RCV) testing is a critical safety requirement in gene therapy development, including CAR-T cell therapy. These tests ensure that viral vectors used in gene therapies are free from replication-capable viruses, which is essential for patient safety and regulatory compliance. At Creative Biolabs, we provide comprehensive RCV testing services with state-of-the-art facilities and extensive expertise in viral vector safety assessment.

Fig. 1 Biologic assays for RCV detection. (Creative Biolabs Original)

Fig. 1 Biologic assays for replication-competent virus detection.

What is RCV/RCL Testing

Definition & Purpose

RCV testing encompasses sophisticated analytical methods designed to detect and quantify replication-competent lentivirus (RCL) or replication-competent retrovirus (RCR) in gene therapy products. The testing process involves multiple complementary techniques, all working together to identify any virus particles that may have regained their ability to replicate independently.

Potential Risks

The presence of replication-competent viruses can lead to severe consequences:

Uncontrolled viral replication in patient tissues
Potential for insertional mutagenesis
Immune system complications
Risk of virus transmission to other tissues

Clinical Impact

Replication-competent viruses can cause serious clinical complications:

Systemic inflammatory responses
Oncogenic transformations
Adverse immune reactions
Potential for germline transmission

Testing Requirements

Regulatory authorities mandate comprehensive testing throughout development:

Master Viral Seed Stock testing
Working Viral Bank testing
End-of-production testing
Process validation samples

Safety Measures

Comprehensive safety measures include:

Multiple testing methods integration
Sensitive detection techniques
Validated analytical procedures
Extensive quality controls

Testing Optimization Strategies

Testing workflow optimization methods include:

Process parameter screening
Testing time optimization
Resource usage efficiency
High-throughput methods
Automation integration

What We Do

AAV Replication Competency Testing

Testing Methods

qPCR-based detection of wild-type AAV sequences
Cell-based assays for replication assessment
Capsid protein analysis
DNA sequence analysis

Parameter	Specification
Sample Requirements	≥ 1×10¹³ vg/mL AAV vector
Sensitivity	≤ 10 copies/reaction

Testing Process

Sample preparation and quality check
Cell culture and infection
Multiple rounds of amplification
Detection and analysis
Result verification and reporting

Lentivirus RCL Testing

Testing Methods

p24 ELISA assay
Vector genome detection
VSV-G envelope testing
Cell-based amplification assay

Parameter	Specification
Sample Volume	≥ 5% of production lot
Detection Limit	1 RCL per 6×10⁸ TU

Retrovirus Testing

Testing Methods

Marker rescue assays
S+L- focus forming assay
Extended S+/L- assay
PCR-based detection

Parameter	Specification
Culture Period	5 passages minimum
Detection Sensitivity	1 RCR per 10⁶ cells

Customized Testing Protocols

Available Customizations

Vector-specific protocol development
Novel serotype testing
Modified capsid testing
Specialized detection methods

Development Process

Initial consultation and requirements analysis
Protocol design and optimization
Method validation
Standard operating procedure development
Quality control implementation

Frequently Asked Questions

What types of samples are suitable for replication-competent virus testing services?

Our Replication-Competent Virus Testing Services are applicable to various types of samples, including:

Biological products such as vaccines, recombinant proteins, and monoclonal antibodies
Cell culture supernatants
Clinical samples such as blood, serum, and cerebrospinal fluid
Viral isolates and viral seed stocks
Non-standard or rare sample types, or complex biological matrices

What is the sensitivity of your replication-competent virus testing services?

The sensitivity of our replication-competent virus testing services depends on the specific detection method employed. qPCR-based methods typically offer high sensitivity, capable of detecting viral genomes at concentrations as low as 10-100 copies/ml. Cell-based assays have slightly lower sensitivity, generally detecting infectious viral particles at levels of 1-10 PFU/ml or 1 TCID50/ml. Protein analysis methods have moderate sensitivity, while the sensitivity of DNA sequencing analysis depends on the sequencing depth, typically detecting low-abundance viral sequences at frequencies of 0.01%-1%. We select the most appropriate testing methods based on our clients' specific requirements, and we can combine multiple methods when necessary to achieve optimal detection performance. We continually validate and improve our testing methods to ensure the highest levels of sensitivity and reliability.

Can you detect multiple viruses simultaneously?

Yes, many of our detection methods can simultaneously detect multiple viruses. qPCR-based methods can utilize multiplex primers and probes or melt curve analysis to differentiate various viruses. Cell-based assays can distinguish multiple viruses by employing different indicator cell lines or observing distinct cytopathic effects. Additionally, high-throughput sequencing technologies enable the simultaneous analysis and identification of all viral sequences present in a sample. We can develop customized multiplex detection methods tailored to the target virus types provided by our clients, fulfilling the need to detect multiple viruses concurrently.